BioVendor R&D offers the world's first microRNA biomarkers quantification assays essential for COVID-19 disease prediction.
Individual TT-PCR assays use our own patented platform to specifically quantify only targeted biomarkers.
Kits labelled with hsa-miR quantify the human miRNAs which are responsible for the immune system, virus-fighting and the development of various severe complications.
Kits starting with sc2v-miR measure the expression of COVID-19 miRNAs which are responsible for infection of host cells, manipulation of the human immune system or targeting the infection to particular organs.
For more details and information, please contact: gresakova@biovendor.com